Nemes Rush Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
18,124
-78,992
| -81% | -$5.45M | 0.14% | 90 |
|
|
2025
Q1 | $6.74M | Buy |
97,116
+13,951
| +17% | +$969K | 0.85% | 39 |
|
|
2024
Q4 | $7.15M | Sell |
83,165
-10,198
| -11% | -$877K | 0.88% | 37 |
|
|
2024
Q3 | $12M | Sell |
93,363
-6,915
| -7% | -$888K | 1.74% | 19 |
|
|
2024
Q2 | $14.3M | Buy |
100,278
+6,114
| +6% | +$873K | 1.97% | 15 |
|
|
2024
Q1 | $12.1M | Buy |
94,164
+93,708
| +20,550% | +$12M | 1.73% | 19 |
|
|
2023
Q4 | $47.2K | Buy |
456
+27
| +6% | +$2.79K | 0.01% | 259 |
|
|
2023
Q3 | $39K | Sell |
429
-93
| -18% | -$8.46K | 0.01% | 279 |
|
|
2023
Q2 | $42.2K | Buy |
+522
| New | +$42.2K | 0.01% | 286 |
|